Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
GROW, School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Immunogenetics. 2020 Sep;72(6-7):339-346. doi: 10.1007/s00251-020-01172-8. Epub 2020 Jun 20.
The HLA-B15 typing by serological approaches defined the serological subgroups (or splits) B62, B63, B75, B76, B77 and B70 (B71 and B72). The scarcity of sera with specific anti-HLA antibodies makes the serological typing method difficult to discriminate a high variety of HLA antigens, especially between the B15 antigen subgroups. Advancements in DNA-based technologies have led to a switch from serological typing to high-resolution DNA typing methods. DNA sequencing techniques assign B15 specificity to all alleles in the HLA-B15 allele group, without distinction of the serological split equivalents. However, the presence of antibodies in the patient defined as split B15 antigens urges the identification of HLA-B15 allele subtypes of the donor, since the presence of donor-specific antibodies is an important contraindication for organ transplantation. Although the HLA dictionary comprises information regarding the serological subtypes of HLA alleles, there are currently 394 B15 antigens out of 516 in the IPD-IMGT/HLA database (3.38.0) without any assigned serological subtype. In this regard, we aimed to identify specific amino acid patterns for each B15 serological split, in order to facilitate the assignment of B15 alleles to serological equivalents after high-resolution molecular typing. As a result, serological specificities of 372/394 not yet assigned alleles could be predicted based on amino acid motifs. Furthermore, two new serological types were identified and added, B62-Bw4 and B71-Bw4.
通过血清学方法对 HLA-B15 进行分型,确定了血清学亚群(或分裂)B62、B63、B75、B76、B77 和 B70(B71 和 B72)。具有特异性抗 HLA 抗体的血清的稀缺性使得血清学分型方法难以区分多种 HLA 抗原,尤其是在 B15 抗原亚群之间。基于 DNA 的技术的进步导致从血清学分型向高分辨率 DNA 分型方法的转变。DNA 测序技术将 B15 特异性分配给 HLA-B15 等位基因组中的所有等位基因,而无需区分血清学分裂等效物。然而,患者体内存在定义为分裂 B15 抗原的抗体促使确定供体的 HLA-B15 等位基因亚型,因为供体特异性抗体的存在是器官移植的重要禁忌症。尽管 HLA 字典包含有关 HLA 等位基因血清学分型的信息,但目前在 IPD-IMGT/HLA 数据库(3.38.0)中,有 516 个 B15 抗原中有 394 个没有分配任何血清学分型。在这方面,我们旨在为每个 B15 血清分裂确定特定的氨基酸模式,以便在高分辨率分子分型后将 B15 等位基因分配给血清等效物。结果,可以根据氨基酸基序预测 372/394 个尚未分配等位基因的血清特异性。此外,还鉴定并添加了两种新的血清类型,B62-Bw4 和 B71-Bw4。